What's New on the FDA Drugs Site
July 31, 2015
- Baxter Initiates Voluntary Nationwide Recall Of One Lot Of Iv Solution Due To The Potential For Leaking Containers, Particulate Matter And Missing Port Protectors
- Dissolution Testing and Specification Criteria for Immediate-Release Solid Oral Dosage Forms Containing Biopharmaceutics Classification System Class 1 and 3 Drugs Guidance for Industry (PDF - 87KB)
- FDA Drug Shortages
- Secretin Synthetic Human (ChiRhoStim) Injection (Updated - Resolved)
- Pediatric Medical, Statistical, and Clinical Pharmacology BPCA and PREA Reviews (updated)
.png)
No hay comentarios:
Publicar un comentario